Q-POC™ platform

Rapid multiplex PCR testing at the point of need

The Q-POC™ platform is a rapid multiplex PCR testing system that delivers fast, accurate and actionable results in approximately 30 minutes at the point of need.

Learn more
Q-POC™ platform

Q-POC™ SARS-CoV-2 Assay

COVID-19 Rapid PCR testing at the point of need

The test delivers COVID-19 Rapid PCR results in 30 minutes at the point of need.

More information

About QuantuMDx

Make life better with multiplex diagnostics at the point of need

We have always believed life for people around the world can be improved if they have better access to the highest quality testing when and where they need it.

Find out more

Designed for the front-line

You no longer need to wait days for test results to inform clinical decisions The Q-POC™ platform compresses an entire molecular diagnosis laboratory into a simple-to-use, accessible and affordable single device that produces results in approximately 30 minutes.

For lab professionals

For lab professionals

Our aim is for Q-POC™ to become the ‘go-to’ point of care PCR system in hospital settings – suitable for…

Read More

For hospital managers

For hospital managers

With its high-quality testing for diseases such as Covid-19, HPV and sexually transmitted infections, Q-POC™ brings the power of rapid…

Read More

For healthcare professionals

For healthcare professionals

Q-POC™ has been designed for busy healthcare professionals. It’s simple and intuitive to use – just input your sample, insert…

Read More

News

Our announcements, achievements and latest news

QuantuMDx confirm its diagnostic tests remain able to detect all known variants of COVID-19 including the new variant from South Africa, B.1.1.529

Following the detection of the variant B.1.1.529, we have performed a detailed analysis to fully assess the reliability of our existing tests

Read More

QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech

QuantuMDx secures £15 million equity investment from Vita Spring and enters into Cooperation Agreement discussions with Sansure Biotech.

Read More

QuantuMDx partners with Cignpost Diagnostics

QuantuMDx is partnering with Cignpost Diagnostics, a leading provider of COVID-19 workplace testing to the film & TV industry.

Read More

QuantuMDx launches Q-POC™ – a PCR diagnostic system

NEWCASTLE UPON TYNE, UK: QuantuMDx today announces the launch of Q-POC™ – a rapid, PCR point of care diagnostic system.…

Read More